The U.S. Food and Drug Administration is studying the possibility of approving the sale of over-the-counter birth control pills.
An advisory committee will meet this week to review the application from HRA Pharma, the French drugmaker owned by Perrigo. The company doesn't expect a final determination to be made before summer. If given the green light, Opill, the contraceptive method that has been marketed for decades, could be purchased in the US without having to see a doctor before.